CRTX - Ticker AI Digest

CRISM Therapeutics Corporation 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (CRTX) 1
CRTX 14:05
CRISM Therapeutics Corporation
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 3
CRTX 06:01
CRISM Therapeutics Corporation
Result of Retail Offer and Additional Placing
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
CRISM Therapeutics Corporation has announced the results of its recent equity issuance, which consisted of a Retail Offer and an Additional Placing. The Retail Offer raised £54,021 through the subscription of 450,176 shares at an issue price of 12 pence per share. Simultaneously, the company conducted an additional placement of 166,666 new ordinary shares at the same issue price, raising £20,000 from an existing shareholder. Combined with the previous Placing announced on June 30, 2025, the company has raised a total of £874,021 in gross proceeds. The proceeds will be utilized to fund the development of ChemoSeed, specifically for GMP manufacture, clinical trial authorization, and the dosing of the first patients in a Phase 2 clinical trial in early 2026. The company has applied for admission of the Retail Offer Shares and Additional Placing Shares to the London Stock Exchange, with trading expected to commence on or around July 8, 2025. Following admission, the total issued share capital of the company will be 39,961,822 ordinary shares, with no shares held in treasury.
CRTX 06:02
CRISM Therapeutics Corporation
Retail Offer
CRTX 06:01
CRISM Therapeutics Corporation
Placing
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
CRTX 06:01
CRISM Therapeutics Corporation
Final Results for the year ended 31 December 2024
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 1
CRTX 14:05
CRISM Therapeutics Corporation
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
CRTX 15:42
CRISM Therapeutics Corporation
Update presentation on the IMC platform
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 7
CRTX 14:05
CRISM Therapeutics Corporation
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
CRTX 06:01
CRISM Therapeutics Corporation
Result of Retail Offer and Additional Placing
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
CRISM Therapeutics Corporation has announced the results of its recent equity issuance, which consisted of a Retail Offer and an Additional Placing. The Retail Offer raised £54,021 through the subscription of 450,176 shares at an issue price of 12 pence per share. Simultaneously, the company conducted an additional placement of 166,666 new ordinary shares at the same issue price, raising £20,000 from an existing shareholder. Combined with the previous Placing announced on June 30, 2025, the company has raised a total of £874,021 in gross proceeds. The proceeds will be utilized to fund the development of ChemoSeed, specifically for GMP manufacture, clinical trial authorization, and the dosing of the first patients in a Phase 2 clinical trial in early 2026. The company has applied for admission of the Retail Offer Shares and Additional Placing Shares to the London Stock Exchange, with trading expected to commence on or around July 8, 2025. Following admission, the total issued share capital of the company will be 39,961,822 ordinary shares, with no shares held in treasury.
CRTX 15:42
CRISM Therapeutics Corporation
Update presentation on the IMC platform
CRTX 06:01
CRISM Therapeutics Corporation
Submission of CTA Application
CRTX 06:02
CRISM Therapeutics Corporation
Retail Offer
CRTX 06:01
CRISM Therapeutics Corporation
Placing
CRTX 06:01
CRISM Therapeutics Corporation
Final Results for the year ended 31 December 2024

AI Crunch

Single-Ticker AI Crunch
CRTX signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for CRISM Therapeutics Corporation. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full CRTX AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for CRTX on 2025-07-10.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
5879972
Enterprise Value
-
Public Float
43.2
Broker Target
-
Shares Out
51735266
Long Interest
-
Short Interest
-
Exchange
-
Currency Code
-
ISIN
VGG042401262
Market
None
Sector
Unknown
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2023-06-01
Earnings Date
-
Net Debt
-1282000.0
Cash
1282000.0
EPS
-0.04
Net Income
-607000.0
Revenue
25000.0
Enterprise Value
-
Trailing PE
-
Forward PE
-
Price Sales TTM
235.1989
Price Book MRQ
5.3315
EV Revenue
228.0904
EV EBITDA
-9.1132

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
2.9403
Institutions As Of
2025-11-27
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
1
Sale Director Dealing
0
Purchase TR1
1
Sale TR1
1
Broker Coverage Rows
0
Institution Holders Tracked
1
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit CRTX.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-07-10 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
CRISM Therapeutics Corporation has fresh news flow feeding the chart narrative.
AI Charts Studio
CRTX Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-07-10 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 3.47%
RSI Gauge
Price Change
AI Forecast